Mareque, M., Montesinos, P., Font, P., Guinea, J., De La Fuente, A., Soto, J., . . . Sierra, J. (2021). Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with cd-33 positive acute myeloid leukaemia in spain.
Citação norma ChicagoMareque, M., et al. Cost-effectiveness Analysis of Gemtuzumab Ozogamicin for First-line Treatment of Patients With Cd-33 Positive Acute Myeloid Leukaemia in Spain. 2021.
Citação norma MLAMareque, M., et al. Cost-effectiveness Analysis of Gemtuzumab Ozogamicin for First-line Treatment of Patients With Cd-33 Positive Acute Myeloid Leukaemia in Spain. 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.